US20020131908A1
(en)
*
|
2000-01-13 |
2002-09-19 |
George Benda |
Selective release apparatus for fluids
|
MXPA03006217A
(es)
*
|
2001-01-12 |
2004-10-15 |
Sun Pharmaceutical Ind Ltd |
Sistema de administracion espaciada de farmacos.
|
KR200249057Y1
(ko)
*
|
2001-03-22 |
2001-10-19 |
김진환 |
뚜껑, 받침대에 합체된 하수역류. 악취방지 장치
|
EP1377276B1
(de)
*
|
2001-04-10 |
2011-10-05 |
Sun Pharma Advanced Research Company Limited |
Zubereitung zur getakteten freisetzung
|
US7083578B2
(en)
*
|
2001-07-12 |
2006-08-01 |
Given Imaging Ltd. |
Device and method for examining a body lumen
|
US7585283B2
(en)
*
|
2001-07-12 |
2009-09-08 |
Given Imaging Ltd. |
Device and method for examining a body lumen
|
US20030175346A1
(en)
*
|
2002-02-01 |
2003-09-18 |
Anne Billotte |
Osmotic delivery system
|
GB0203296D0
(en)
*
|
2002-02-12 |
2002-03-27 |
Glaxo Group Ltd |
Novel composition
|
ITMI20020515A1
(it)
*
|
2002-03-12 |
2003-09-12 |
Jagotec Ag |
Sistema per il rilasco controllato di uno o piu' principi attivi
|
ITMI20020514A1
(it)
*
|
2002-03-12 |
2003-09-12 |
Jagotec Ag |
Sistema terapeutico per il rilascio controllato di uno o piu' principi attivi
|
US8523788B2
(en)
*
|
2002-07-11 |
2013-09-03 |
Given Imaging Ltd. |
Device, system and method for examining a body lumen
|
US20050232995A1
(en)
|
2002-07-29 |
2005-10-20 |
Yam Nyomi V |
Methods and dosage forms for controlled delivery of paliperidone and risperidone
|
US20050208132A1
(en)
*
|
2002-07-29 |
2005-09-22 |
Gayatri Sathyan |
Methods and dosage forms for reducing side effects of benzisozazole derivatives
|
US7785627B2
(en)
*
|
2002-09-20 |
2010-08-31 |
Watson Pharmaceuticals, Inc. |
Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative
|
US9060941B2
(en)
*
|
2002-09-20 |
2015-06-23 |
Actavis, Inc. |
Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative
|
US7959946B2
(en)
|
2002-09-20 |
2011-06-14 |
Watson Pharmaceuticals, Inc. |
Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative
|
US8084058B2
(en)
|
2002-09-20 |
2011-12-27 |
Watson Pharmaceuticals, Inc. |
Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative
|
US8293799B2
(en)
*
|
2003-12-29 |
2012-10-23 |
Osmotica Keresleedelmo és Szolgáltató KFT |
Osmotic device containing a venlafaxine salt and a salt having an ion in common
|
WO2004108067A2
(en)
*
|
2003-04-03 |
2004-12-16 |
Sun Pharmaceutical Industries Limited |
Programmed drug delivery system
|
DE602004023597D1
(de)
*
|
2003-04-24 |
2009-11-26 |
Jagotec Ag |
Tablette mit gefärbtem kern
|
PT1631251E
(pt)
*
|
2003-04-24 |
2011-09-19 |
Jagotec Ag |
Comprimido de libertação retardada com geometria de núcleo definida
|
UY28326A1
(es)
*
|
2003-05-22 |
2004-06-30 |
Osmotica Argentina S A |
Dispositivo de ruptura de liberacion controlada con un pasaje preformado
|
US20060177507A1
(en)
*
|
2003-05-22 |
2006-08-10 |
Joaquina Faour |
Controlled release device containing lercanidipine
|
US8029822B2
(en)
*
|
2003-05-22 |
2011-10-04 |
Osmotica Kereskedelmi és Seolgáltató KFT |
Rupturing controlled release device having a preformed passageway
|
JP2007503389A
(ja)
*
|
2003-08-22 |
2007-02-22 |
アルザ・コーポレーシヨン |
長期間にわたるトピラメートの段階的送達
|
US7611728B2
(en)
*
|
2003-09-05 |
2009-11-03 |
Supernus Pharmaceuticals, Inc. |
Osmotic delivery of therapeutic compounds by solubility enhancement
|
DE10351448A1
(de)
*
|
2003-11-04 |
2005-06-09 |
Bayer Healthcare Ag |
Geschmackstoffhaltige Arzneimittelformulierungen mit verbesserten pharmazeutischen Eigenschaften
|
US20050201974A1
(en)
*
|
2003-12-09 |
2005-09-15 |
Spherics, Inc. |
Bioadhesive polymers with catechol functionality
|
SE0401031D0
(sv)
*
|
2004-04-22 |
2004-04-22 |
Duocort Ab |
A new glucocorticoid replacement therapy
|
US8574626B2
(en)
|
2004-12-03 |
2013-11-05 |
Osmotica Kereskedelmi és Szolgáltató KFT |
Osmotic device containing amantadine and an osmotic salt
|
US8252331B2
(en)
*
|
2004-12-03 |
2012-08-28 |
Osmotica Kereskedelmi és Szolgáltató, KFT |
Osmotic device containing amantadine and an osmotic salt
|
AR053986A1
(es)
|
2004-12-03 |
2007-05-30 |
Osmotica Pharmaceutical Argent |
Dispositivo osmotico que contiene amantadina y una sal osmotica
|
US8912908B2
(en)
|
2005-04-28 |
2014-12-16 |
Proteus Digital Health, Inc. |
Communication system with remote activation
|
US9198608B2
(en)
|
2005-04-28 |
2015-12-01 |
Proteus Digital Health, Inc. |
Communication system incorporated in a container
|
US8802183B2
(en)
|
2005-04-28 |
2014-08-12 |
Proteus Digital Health, Inc. |
Communication system with enhanced partial power source and method of manufacturing same
|
CA2789262C
(en)
|
2005-04-28 |
2016-10-04 |
Proteus Digital Health, Inc. |
Pharma-informatics system
|
US8836513B2
(en)
|
2006-04-28 |
2014-09-16 |
Proteus Digital Health, Inc. |
Communication system incorporated in an ingestible product
|
RU2408368C2
(ru)
*
|
2005-06-27 |
2011-01-10 |
Биовэйл Лэборэториз Интернэшнл С.Р.Л. |
Препараты соли бупропиона с модифицированным высвобождением
|
US20070003624A1
(en)
*
|
2005-06-29 |
2007-01-04 |
Shanbhag Anant R |
Semi-permeable compositions providing reduced drying time for osmotic dosage forms
|
KR101568660B1
(ko)
|
2006-05-02 |
2015-11-12 |
프로테우스 디지털 헬스, 인코포레이티드 |
환자 주문형 치료법
|
US7772390B1
(en)
|
2006-07-18 |
2010-08-10 |
The Regents Of The University Of California |
Lipid mediated nucleic acid synthesis
|
EA015304B1
(ru)
|
2006-08-03 |
2011-06-30 |
Нитек Фарма Аг |
Лечение ревматоидного заболевания глюкокортикоидами с отсроченным высвобождением
|
MY158019A
(en)
|
2006-10-25 |
2016-08-30 |
Proteus Digital Health Inc |
Controlled activation ingestible identifier
|
US8718193B2
(en)
|
2006-11-20 |
2014-05-06 |
Proteus Digital Health, Inc. |
Active signal processing personal health signal receivers
|
JP5524626B2
(ja)
|
2007-02-01 |
2014-06-18 |
プロテウス デジタル ヘルス, インコーポレイテッド |
摂取可能な事象マーカシステム
|
CN103066226B
(zh)
|
2007-02-14 |
2016-09-14 |
普罗透斯数字保健公司 |
具有高表面积电极的体内电源
|
US9270025B2
(en)
|
2007-03-09 |
2016-02-23 |
Proteus Digital Health, Inc. |
In-body device having deployable antenna
|
US8932221B2
(en)
|
2007-03-09 |
2015-01-13 |
Proteus Digital Health, Inc. |
In-body device having a multi-directional transmitter
|
US8115618B2
(en)
|
2007-05-24 |
2012-02-14 |
Proteus Biomedical, Inc. |
RFID antenna for in-body device
|
BRPI0812918A2
(pt)
*
|
2007-06-21 |
2014-12-09 |
Swelltec Ltd |
Aparelho e método com corpo dilatável em hidrocarboneto e dilatável em água
|
GB0711979D0
(en)
*
|
2007-06-21 |
2007-08-01 |
Swelltec Ltd |
Method and apparatus
|
US20090004281A1
(en)
*
|
2007-06-26 |
2009-01-01 |
Biovail Laboratories International S.R.L. |
Multiparticulate osmotic delivery system
|
US8637080B2
(en)
*
|
2007-06-28 |
2014-01-28 |
Osmotica Kereskedelmi és Szolgáltató, KFT |
Rupturing controlled release device comprising a subcoat
|
FI2192946T3
(fi)
|
2007-09-25 |
2022-11-30 |
|
Elimistön sisäinen laite, jossa on virtuaalinen dipolisignaalinvahvistus
|
CN104376659B
(zh)
|
2008-03-05 |
2019-10-25 |
普罗透斯数字保健公司 |
多模式通信可摄取事件标记和系统,及使用其的方法
|
US20090312627A1
(en)
*
|
2008-06-16 |
2009-12-17 |
Matott Laura A |
Radio-labeled ingestible capsule
|
ES2696984T3
(es)
|
2008-07-08 |
2019-01-21 |
Proteus Digital Health Inc |
Infraestructura de datos de marcadores de eventos de ingestión
|
WO2010015840A1
(en)
*
|
2008-08-08 |
2010-02-11 |
Cipla Limited |
Osmotic delivery device with modified release
|
CN104382598A
(zh)
|
2008-08-13 |
2015-03-04 |
普罗透斯数字保健公司 |
一种产生识别器的方法
|
US20100068153A1
(en)
*
|
2008-09-16 |
2010-03-18 |
Searete Llc, A Limited Liability Corporation Of The State Of Delaware |
Ex vivo activatable final dosage form
|
US20100068254A1
(en)
*
|
2008-09-16 |
2010-03-18 |
Mahalaxmi Gita Bangera |
Modifying a medicament availability state of a final dosage form
|
US20100069887A1
(en)
*
|
2008-09-16 |
2010-03-18 |
Searete Llc, A Limited Liability Corporation Of The State Of Delaware |
Multiple chamber ex vivo adjustable-release final dosage form
|
US20100068275A1
(en)
*
|
2008-09-16 |
2010-03-18 |
Searete Llc, A Limited Liability Corporation Of The State Of Delaware |
Personalizable dosage form
|
US20100069821A1
(en)
*
|
2008-09-16 |
2010-03-18 |
Searete Llc, A Limited Liability Corporation Of The State Of Delaware |
Ex vivo modifiable medicament release-sites final dosage form
|
US20100068278A1
(en)
*
|
2008-09-16 |
2010-03-18 |
Searete Llc, A Limited Liablity Corporation Of The State Of Delaware |
Ex vivo modifiable medicament release-associations
|
US20100068152A1
(en)
*
|
2008-09-16 |
2010-03-18 |
Searete Llc, A Limited Liability Corporation Of The State Of Delaware |
Ex vivo modifiable particle or polymeric based final dosage form
|
US20100068235A1
(en)
*
|
2008-09-16 |
2010-03-18 |
Searete LLC, a limited liability corporation of Deleware |
Individualizable dosage form
|
US20100068233A1
(en)
*
|
2008-09-16 |
2010-03-18 |
Searete Llc, A Limited Liability Corporation Of The State Of Delaware |
Modifiable dosage form
|
JP5785097B2
(ja)
|
2009-01-06 |
2015-09-24 |
プロテウス デジタル ヘルス, インコーポレイテッド |
薬学的投薬量送達システム
|
CN102341031A
(zh)
|
2009-01-06 |
2012-02-01 |
普罗秋斯生物医学公司 |
摄取相关的生物反馈和个人化医学治疗方法和系统
|
WO2010084188A1
(en)
*
|
2009-01-26 |
2010-07-29 |
Nitec Pharma Ag |
Delayed-release glucocorticoid treatment of asthma
|
NZ582836A
(en)
*
|
2009-01-30 |
2011-06-30 |
Nitec Pharma Ag |
Delayed-release glucocorticoid treatment of rheumatoid arthritis by improving signs and symptoms, showing major or complete clinical response and by preventing from joint damage
|
WO2010111403A2
(en)
|
2009-03-25 |
2010-09-30 |
Proteus Biomedical, Inc. |
Probablistic pharmacokinetic and pharmacodynamic modeling
|
NZ619375A
(en)
|
2009-04-28 |
2015-03-27 |
Proteus Digital Health Inc |
Highly reliable ingestible event markers and methods for using the same
|
WO2010132331A2
(en)
*
|
2009-05-12 |
2010-11-18 |
Proteus Biomedical, Inc. |
Ingestible event markers comprising an ingestible component
|
TWI517050B
(zh)
|
2009-11-04 |
2016-01-11 |
普羅托斯數位健康公司 |
供應鏈管理之系統
|
WO2011079050A2
(en)
|
2009-12-23 |
2011-06-30 |
The Smart Pill Corporation |
Method of evaluating constipation using an ingestible capsule
|
RU2012143791A
(ru)
|
2010-04-07 |
2014-05-20 |
Проутьюс Диджитал Хэлс, Инк. |
Миниатюрное проглатываемое устройство
|
TWI557672B
(zh)
|
2010-05-19 |
2016-11-11 |
波提亞斯數位康健公司 |
用於從製造商跟蹤藥物直到患者之電腦系統及電腦實施之方法、用於確認將藥物給予患者的設備及方法、患者介面裝置
|
JP2014504902A
(ja)
|
2010-11-22 |
2014-02-27 |
プロテウス デジタル ヘルス, インコーポレイテッド |
医薬品を有する摂取可能なデバイス
|
US9756874B2
(en)
|
2011-07-11 |
2017-09-12 |
Proteus Digital Health, Inc. |
Masticable ingestible product and communication system therefor
|
WO2015112603A1
(en)
|
2014-01-21 |
2015-07-30 |
Proteus Digital Health, Inc. |
Masticable ingestible product and communication system therefor
|
IN2014MN00183A
(de)
|
2011-07-21 |
2015-06-19 |
Proteus Digital Health Inc |
|
US9235683B2
(en)
|
2011-11-09 |
2016-01-12 |
Proteus Digital Health, Inc. |
Apparatus, system, and method for managing adherence to a regimen
|
KR20150038038A
(ko)
|
2012-07-23 |
2015-04-08 |
프로테우스 디지털 헬스, 인코포레이티드 |
섭취 가능한 부품을 포함하는 섭취 가능한 이벤트 마커를 제조하기 위한 기술
|
CN102871982B
(zh)
*
|
2012-10-16 |
2014-09-10 |
中国科学院上海药物研究所 |
一种药物渗透泵制剂
|
DK2910013T3
(en)
|
2012-10-18 |
2018-08-06 |
Proteus Digital Health Inc |
Apparatus, system and method for adaptive optimization for power output and transmit power in a power source for a communication device
|
WO2014120669A1
(en)
|
2013-01-29 |
2014-08-07 |
Proteus Digital Health, Inc. |
Highly-swellable polymeric films and compositions comprising the same
|
US10175376B2
(en)
|
2013-03-15 |
2019-01-08 |
Proteus Digital Health, Inc. |
Metal detector apparatus, system, and method
|
JP6511439B2
(ja)
|
2013-06-04 |
2019-05-15 |
プロテウス デジタル ヘルス, インコーポレイテッド |
データ収集および転帰の査定のためのシステム、装置、および方法
|
US9796576B2
(en)
|
2013-08-30 |
2017-10-24 |
Proteus Digital Health, Inc. |
Container with electronically controlled interlock
|
US9566248B2
(en)
*
|
2013-09-13 |
2017-02-14 |
R.P. Scherer Technologies, Llc |
Encased-pellet tablets
|
US10084880B2
(en)
|
2013-11-04 |
2018-09-25 |
Proteus Digital Health, Inc. |
Social media networking based on physiologic information
|
US20150307754A1
(en)
*
|
2014-04-28 |
2015-10-29 |
Celanese Acetate Llc |
Adhesives that include highly-plasticized cellulose esters and methods and articles relating thereto
|
WO2016132233A1
(en)
|
2015-02-20 |
2016-08-25 |
Osmotica Kereskedelmi Es Szolgaltato Kft |
Controlled release oral dosage form of gaba receptor agonist with enhanced pharmacokinetics
|
US10987328B2
(en)
|
2015-02-20 |
2021-04-27 |
Osmotica Kereskedelmi Es Szolgaltato Kft |
Controlled release dosage form
|
US10172800B2
(en)
|
2015-02-20 |
2019-01-08 |
Osmotica Kereskedelmi Es Szolgaltato Kft |
Controlled release dosage form with enhanced pharmacokinetics
|
US10300032B2
(en)
|
2015-02-20 |
2019-05-28 |
Osmotica Kereskedelmi Es Szolgaltato Kft |
Controlled release dosage form
|
US11051543B2
(en)
|
2015-07-21 |
2021-07-06 |
Otsuka Pharmaceutical Co. Ltd. |
Alginate on adhesive bilayer laminate film
|
BR112019000861B1
(pt)
|
2016-07-22 |
2020-10-27 |
Proteus Digital Health, Inc |
dispositivo eletrônico
|
TWI735689B
(zh)
|
2016-10-26 |
2021-08-11 |
日商大塚製藥股份有限公司 |
製造含有可攝食性事件標記之膠囊之方法
|
US10213393B1
(en)
|
2018-02-15 |
2019-02-26 |
Osmotica Kereskedelmi és Szolgáltató Korlátolt Feleõsségû Társaság |
Composition and method for treating neurological disease
|
US20190247331A1
(en)
|
2018-02-15 |
2019-08-15 |
Osmotica Kereskedelmi és Szolgáltató Korlátolt Felelõsségû Társaság |
Composition and method for treating neurological disease
|
US10213394B1
(en)
|
2018-02-15 |
2019-02-26 |
Osmotica Kereskedelmi és Szolgáltató Korlátolt Felelõsségû Társaság |
Composition and method for treating neurological disease
|